Menu Back toQuality by Design for Clinical Trials: A Hands-On, Multi-Stakeholder Workshop
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Quality by Design for Clinical Trials: A Hands-On, Multi-Stakeholder Workshop
- Senior Project Manager
- Clinical Trials Transformation Initiative (CTTI), United States
The modernization of ICH E8 emphasizes a Quality by Design (QbD) approach to trial design. In this workshop, apply new resources to capture key design decisions, define organizational strategy for implementation, and identify metrics for tracking progress.
Learning Objective : Apply new resources supporting key elements of quality by design (QbD), including capturing trial-specific factors that are critical to successful completion and safety, and proactively addressing risks of ‘errors that matter’; Design an organizational strategy for implementing QbD, including application of a maturity model and metrics framework to evaluate current state, identify priorities, and track progress.
Ansalan Stewart, PhD
- Health Scientist Policy Analyst, OMP, CDER
- FDA, United States
- Director Organizational Excellence
- Janssen-Cilag GmbH, Germany
- Senior Director, Process Quality Management
- Syneos Health, United Kingdom